Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents
Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed’s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intelligence algorithms.
Abiomed is recognized as a leader in technology and innovation, with robust clinical data supporting the regulatory approvals and physician adoption of its technologies. The company employs several hundred engineers and scientists at its state-of-the-art research and development facilities in Danvers, Massachusetts, Aachen, Germany, and Berlin, Germany. Over the past 20 years, Abiomed has grown its product pipeline by investing more than $600 million in research and development.
“At Abiomed, we strive to develop smaller, smarter and more connected technologies for our customers and patients,” said Michael R. Minogue, Abiomed’s Chairman, President and Chief Executive Officer. “Abiomed will continue to innovate new technologies that address clinical challenges and help physicians recover hearts, oxygenate the body and save lives.”
Based in Danvers, Massachusetts, USA, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com .
This press release contains forward-looking statements. Forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-H2O.AI26.1.2021 17:21:12 CET | Press release
H2O.ai Launches H2O AI Hybrid Cloud
IL-ISACA26.1.2021 17:18:12 CET | Press release
ISACA Releases New Report on Privacy Trends, Obstacles and Predictions Ahead of Data Privacy Day
CA-XSOLLA26.1.2021 16:03:08 CET | Press release
Xsolla Launches New Mobile Game Commerce Solution to Help Developers Expand Their Mobile Business
MA-BRIGHTCOVE26.1.2021 15:02:14 CET | Press release
Brightcove Receives Two Technology and Engineering Emmy® Awards
CA-MOODY’S-ANALYTICS26.1.2021 15:02:04 CET | Press release
Moody’s Analytics CECL Solutions Complete 2020 SOC 1® Examinations
PA-PROFIL/PENNENGINE26.1.2021 15:02:04 CET | Press release
PROFIL® Launches New Website
MUNDIPHARMA26.1.2021 14:02:08 CET | Press release
Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom